Stock screenerAll disclosures →
EDGAR →
TYRA
Conviction 42HealthcareScan · Mon, Aug 10, 2026TYRA$26.23-1.08%
ResistanceSupportVol 14Vol MA14 795.18K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price26.23
Change-1.08%
Gap-1.58%
Rel volume2.12×
Avg volume694.92K
Avg $ vol20.44M
SMA 2030.59
SMA 5030.06
SMA 20029.28
Price vs 50-12.75%
Price vs 200-10.44%
MA stackmixed
50/200 cross—
Supertrenddown · 32.33
RSI (14)35
MACD hist-0.66
MACD crossbear · 3d
Stoch %K / %D10 / 14
ADX (14)20
+DI / −DI12 / 29
RSI divergenceBearish
MACD divergenceBearish
ATR %+7.42%
ADR %5.96%
52w high39.61
52w low10.10
From 52w high-33.79%
Above 52w low+159.65%
New 52w highNo
SqueezeOff
Bollinger width29.32%
%B0.01
Donchian pos9.23%
Donchian high33.72
Donchian low25.46
AVWAP (52w high)32.27
vs AVWAP high-18.73%
AVWAP (52w low)29.86
vs AVWAP low-12.19%
OBV trendDown
Chaikin MF (20)-0.17
Today vs 20d2.12×
Avg vol (14d)795.18K
Avg vol (20d)694.92K
Avg $ vol (20d)20.44M
Market cap1.57B
RS 3m (vs SPY)-25.12%
RS 6m (vs SPY)-24.13%
RS line new highNo
Trend template3/8
Technical rank18.3
1 week-18.15%
1 month-19.92%
3 months-23.59%
6 months-15.40%
1 year+143.95%
YTD-2.11%
P/E-13.05
P/B4.43
P/S—
P/FCF-16.43
EPS-2.01
Div yield—
ROE-33.92%
ROA-31.29%
Debt/Eq—
Current14.91
EV/EBITDA-11.28
Gross margin—
Net margin—
Rev growth—
EPS growth-38.70%
Price target49.63
Target upside89.25%
Analyst ratingBuy
Institutional117.77%
Ent. value1.49B
Revenue—
Net income-45.56M
Gross profit—
Free cash flow-95.28M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out59.47M
Employees87
ListedWed, Sep 15, 2021
Free float28.09M
Float %52.1%
Short interest9.93M
Days to cover15.5d
Short volume66.8%
Squeeze score98 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.69 vs −$0.67
Last surprise-3.0% miss
Setup gradeD
Conviction42 / 100
Pattern quality—
Tech rank18.3 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance33.50
Support27.36
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in TYRA
No recent disclosed trades by Congress in TYRA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in TYRA · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Shah Rajeev M. Director · Stock Option (Right to Buy) · 2026-05-28 | Grant | 13.16K | $0 | 2026-05-28 | 2026-06-01 |
Kolchinsky Peter Director · Stock Option (Right to Buy) · 2026-05-28 | Grant | 13.16K | $0 | 2026-05-28 | 2026-06-01 |
Simson Jake Director · Stock Option (Right to Buy) · 2026-05-28 | Grant | 13.16K | $0 | 2026-05-28 | 2026-06-01 |
MORE ROBERT J Director · Stock Option (Right to Buy) · 2026-05-28 | Grant | 13.16K | $0 | 2026-05-28 | 2026-06-01 |
RA Capital Nexus Fund, L.P. Director · Stock Option (Right to Buy) · 2026-05-28 | Grant | 13.16K | $0 | 2026-05-28 | 2026-06-01 |
RA Capital Healthcare Fund LP Director · Stock Option (Right to Buy) · 2026-05-28 | Grant | 13.16K | $0 | 2026-05-28 | 2026-06-01 |
Verjee Rehan Director · Stock Option (Right to Buy) · 2026-05-28 | Grant | 13.16K | $0 | 2026-05-28 | 2026-06-01 |
RA CAPITAL MANAGEMENT, L.P. Director · Stock Option (Right to Buy) · 2026-05-28 | Grant | 13.16K | $0 | 2026-05-28 | 2026-06-01 |
Moran Susan Director · Stock Option (Right to Buy) · 2026-05-28 | Grant | 13.16K | $0 | 2026-05-28 | 2026-06-01 |
Rothenberg Stephen Michael Director · Stock Option (Right to Buy) · 2026-05-28 | Grant | 13.16K | $0 | 2026-05-28 | 2026-06-01 |
SEC filings
EDGAR filings in TYRA · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.